Across TCGA pan-cancer cohorts, SNORD115-24 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated SNORD115-24 data layer compared with 2 for mutation status.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher SNORD115-24 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORD115-24 expression acts as an unfavorable survival marker.

STAD and KIRC are the cancer types where SNORD115-24 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	All	0.255	0.664	<.001	63	view →
KIRC	OS	Tertile	II,III,IV	0.193	0.806	.011	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: SNORD115-24 tumor-vs-normal RNA expression · all SNORD115-24 data types